KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 75 filers reported holding KALA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $527,000 | -50.5% | 201,005 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $1,065,000 | -21.4% | 201,005 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,355,000 | -0.6% | 201,005 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,363,000 | -9.6% | 201,005 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $1,508,000 | -28.6% | 201,005 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $2,113,000 | +13.9% | 201,005 | -4.7% | 0.01% | -16.7% |
| Q1 2020 | $1,855,000 | +138.1% | 211,005 | 0.0% | 0.01% | +200.0% |
| Q4 2019 | $779,000 | -3.0% | 211,005 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $803,000 | -40.3% | 211,005 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $1,346,000 | -22.9% | 211,005 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $1,745,000 | +69.1% | 211,005 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $1,032,000 | -50.5% | 211,005 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $2,083,000 | -28.1% | 211,005 | 0.0% | 0.01% | -33.3% |
| Q2 2018 | $2,897,000 | -26.8% | 211,005 | -15.6% | 0.01% | -30.8% |
| Q1 2018 | $3,957,000 | – | 250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 1 | $9 | 0.00% |